| Practical management of lupus nephritis in pregnancy and the puerperium. | |
| | |
MedLine Citation:
|
PMID: 22111780 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Pregnancy represents a major challenge in the management of patients with systemic lupus erythematosus, with substantial risks to both mother and baby. Over the past 40 years there have been major improvements in outcomes. This partly relates to the discovery of the antiphospholipid syndrome, which has transformed management of lupus pregnancy, but also due to more effective drugs and better obstetric practice. Despite these advances, significant maternal and fetal morbidity may still occur in patients with lupus nephritis, and there remain ongoing challenges in order to improve outcomes further. In this article we focus on the challenges facing lupus nephritis patients considering pregnancy, and discuss how we approach practical management issues in relation to the current literature. |
| | |
Authors:
|
M Yousuf Karim; David P D'Cruz |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert review of clinical pharmacology Volume: 3 ISSN: 1751-2441 ISO Abbreviation: Expert Rev Clin Pharmacol Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2011-11-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278296 Medline TA: Expert Rev Clin Pharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 777-84 Citation Subset: IM |
Affiliation:
|
The Lupus Research Unit, The Rayne Institute, 4th Floor, Lambeth Wing, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity.
Next Document: Novel therapeutic strategies following docetaxel-based chemotherapy in castration-resistant prostate...